Hershey Trust Company’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-19,048
Closed -$1.54M 24
2020
Q2
$1.54M Sell
19,048
-28,574
-60% -$2.3M 0.02% 3
2020
Q1
$3.31M Buy
47,622
+14,288
+43% +$1.1M 0.04% 6
2019
Q4
$2.6M Sell
33,334
-4,762
-13% -$343K 0.03% 4
2019
Q3
$2.43M Buy
+38,096
New +$3.36M 0.03% 4

Other funds holding GH

Hershey Trust Company's GH Position: Q3 2020 in Review

Hershey Trust Company sold out of Guardant Health (GH) in Q3 2020, closing a stake of 19,048 shares — an estimated $1.54M sold.

Hershey Trust Company first reported a position in GH in Q3 2019 and held it in 4 quarters. The position peaked at $3.31M in Q1 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Hershey Trust Company reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • Hershey Trust Company sold 19,048 Guardant Health shares in Q3 2020, an estimated $1.54M.
  • Hershey Trust Company first reported a position in Guardant Health in Q3 2019 and held it in 4 quarters.
  • Hershey Trust Company's Guardant Health position peaked at $3.31M in Q1 2020.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Hershey Trust Company's 13F filing for Q3 2020, filed 23 Oct 2020.